PIGMENTED BASAL CELL CARCINOMA SUCCESSFULLY TREATED WITH 5% IMIQUIMOD CREAM

Basal cell carcinoma (BCC) is the most common malignant skin tumor, amongst which the nodular, nodulo ulcerative and superficial types comprise nearly 80% of all BCCs. Topical Imiquimod, an immune response modifier has been found to be effective in superficial and nodular types of BCC with histologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Vandana, Balachandran, C
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2008
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763750/
https://www.ncbi.nlm.nih.gov/pubmed/19882014
http://dx.doi.org/10.4103/0019-5154.43204
_version_ 1782173034413555712
author Mehta, Vandana
Balachandran, C
author_facet Mehta, Vandana
Balachandran, C
author_sort Mehta, Vandana
collection PubMed
description Basal cell carcinoma (BCC) is the most common malignant skin tumor, amongst which the nodular, nodulo ulcerative and superficial types comprise nearly 80% of all BCCs. Topical Imiquimod, an immune response modifier has been found to be effective in superficial and nodular types of BCC with histological clearance rates of up to 100%. We report our experience of treatment a large pigmented BCC on the face with topical Imiquimod 5% cream.
format Text
id pubmed-2763750
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-27637502009-10-29 PIGMENTED BASAL CELL CARCINOMA SUCCESSFULLY TREATED WITH 5% IMIQUIMOD CREAM Mehta, Vandana Balachandran, C Indian J Dermatol Case Report Basal cell carcinoma (BCC) is the most common malignant skin tumor, amongst which the nodular, nodulo ulcerative and superficial types comprise nearly 80% of all BCCs. Topical Imiquimod, an immune response modifier has been found to be effective in superficial and nodular types of BCC with histological clearance rates of up to 100%. We report our experience of treatment a large pigmented BCC on the face with topical Imiquimod 5% cream. Medknow Publications 2008 /pmc/articles/PMC2763750/ /pubmed/19882014 http://dx.doi.org/10.4103/0019-5154.43204 Text en © Indian Journal of Dermatology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Mehta, Vandana
Balachandran, C
PIGMENTED BASAL CELL CARCINOMA SUCCESSFULLY TREATED WITH 5% IMIQUIMOD CREAM
title PIGMENTED BASAL CELL CARCINOMA SUCCESSFULLY TREATED WITH 5% IMIQUIMOD CREAM
title_full PIGMENTED BASAL CELL CARCINOMA SUCCESSFULLY TREATED WITH 5% IMIQUIMOD CREAM
title_fullStr PIGMENTED BASAL CELL CARCINOMA SUCCESSFULLY TREATED WITH 5% IMIQUIMOD CREAM
title_full_unstemmed PIGMENTED BASAL CELL CARCINOMA SUCCESSFULLY TREATED WITH 5% IMIQUIMOD CREAM
title_short PIGMENTED BASAL CELL CARCINOMA SUCCESSFULLY TREATED WITH 5% IMIQUIMOD CREAM
title_sort pigmented basal cell carcinoma successfully treated with 5% imiquimod cream
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763750/
https://www.ncbi.nlm.nih.gov/pubmed/19882014
http://dx.doi.org/10.4103/0019-5154.43204
work_keys_str_mv AT mehtavandana pigmentedbasalcellcarcinomasuccessfullytreatedwith5imiquimodcream
AT balachandranc pigmentedbasalcellcarcinomasuccessfullytreatedwith5imiquimodcream

Ejemplares similares